US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Switzerland Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... will translate into greater demand for drugs. Furthermore, the country's highly developedinfrastructure means that access to healthcare is easy, further supporting the consumption of medicines. Headline Expenditure Projections Pharmaceuticals: CHF7.06bn (USD7.68bn) in 2013 to CHF7.02bn ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... beyond 2014. This drop in spendingreflects the UK government's focus on containing costs within the healthcare sector, and in particularpharmaceutical expenditure. Headline Expenditure Projections Pharmaceuticals: GBP23.32bn (USD36.15bn) in 2013 to GBP22.90bn (USD37.33bn) in 2014;-1.8% in ...  |  read more...
USD 1,295
Venezuela Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... of local medicines in the near term. However, fundamental issues - such as price controls, highinflation, currency devaluation, import and foreign currency controls and the government's attitude towardsnormal business practices - have not changed. We ...  |  read more...
USD 1,295
Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014
9/24/2014 | published by: Business Monitor International
... in themedium-to-long term. The already dire situation, in which the health service is heavily reliant on donations,lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget isnot even ...  |  read more...
USD 1,295
Healthcare in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
... (RETAIL) LTD. Covering activities such as healthcare, medical, health, pharmaceutical, home and includes a wealth of information on the financial trends over the past four years. latest Healthcare analysis is perfect for investors to: See ...  |  read more...
USD 525
Pharmaceuticals and Healthcare Report - Cambodia and Laos Q4 2014
10/1/2014 | published by: Business Monitor International
... that Cambodia will remain oneof the least attractive markets in South East Asia. Headline Expenditure Projections Pharmaceuticals: KHR821.7bn (USD204mn) in 2013 to KHR908.9bn (USD227mn) in 2014; +10.6% inlocal currency terms and +11.2% in US dollar ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Cuba Q4 2014
10/1/2014 | published by: Business Monitor International
... ensure that the domestic industry continuesto outpace other sectors. More foreign companies will look to embrace emerging opportunities in thecountry, which desires greater involvement in the global economy. 0Headline Expenditure Projections Pharmaceuticals: CUP1.35bn (USD1.35bn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Saudi Arabia Q4 2014
10/1/2014 | published by: Business Monitor International
... governmentinitiatives. The new health projects will increase access to healthcare and provide revenue-earningopportunities for drugmakers, medical device companies and healthcare service providers. Thegovernment's planned privatisation of the healthcare industry will increase investment in the sector, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Slovakia Q4 2014
10/1/2014 | published by: Business Monitor International
... autumn this year. Medical fees byhospitals and doctors are symptomatic of the chronic inefficiency of healthcare funding within Slovakia. With the healthcare system set to come under the complete control of the Slovak state, funding ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Spain Q4 2014
10/1/2014 | published by: Business Monitor International
... follow suit until 2018. Regardless of callsmade by companies for the implementation of a system that adequately rewards innovation and supportsinvestment in future medicines, the government will likely continue with its cost containment measures bytargeting ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Vietnam Q4 2014
10/1/2014 | published by: Business Monitor International
... infrastructure and personnel, growth in expenditure is supported by a significant diseaseburden, the new insurance law, introduction of new products, more corporate investments and betterregulations. Headline Expenditure Projections Pharmaceuticals: VND69,297bn (USD3.30bn) in 2013 to VND80,680bn ...  |  read more...
USD 1,295
Online Pharmaceutical Sales in Australia - Industry Market Research Report
9/24/2014 | published by: IBISWorld
... dual presence (both physical stores and online operations). This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth ...  |  read more...
USD 965
Pharmacies in Australia - Industry Market Research Report
9/12/2014 | published by: IBISWorld
... pharmacy groups include independent community pharmacies, banner groups (both wholesaler-owned and independent), friendly societies, buying groups and discount pharmacies. This report covers the scope, size, disposition and growth of the industry including the key sensitivities ...  |  read more...
USD 965
Austria Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... Commerce department has listed Austria as one of the most attractive countries in which to markethealthcare technologies, while one of its domestic pharmaceutical firms has announced success indeveloping a cure for Alzheimer's. We believe that ...  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... new headquarters' domicile in Ireland,although the megatrend of consolidation within the pharmaceutical industry, including cross-bordermergers and redomiciling in Ireland for tax saving purposes, is expected to continue over the near term. More broadly, due to ...  |  read more...
USD 1,295
Myanmar Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... the growth of theeconomy. Headline Expenditure Projections Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014;+19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previousquarter. Healthcare Expenditure: MMK1,047.3bn ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q4 2014
9/24/2014 | published by: Business Monitor International
... investment and interest in the country's pharmaceutical market. Nevertheless, the government'sintention to improve healthcare through the implementation of a universal healthcare scheme will continueto present significant revenue-generating opportunities for firms over the long term. Headline ...  |  read more...
USD 1,295
China Pharmaceutical Mfg. Industry Data Report
9/28/2014 | published by: Beijing Zeefer Consulting Ltd.
... 2011 to 2013, and reveals differences in various regions of Mainland China in terms of pharmaceutical mfg. sector, provides an important reference for investors' selection of target regions to make investment based on Zeefer Industry ...  |  read more...
USD 580
Pharmaceuticals in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
... activities such as pharmaceutical, healthcare, clinical trials, medicine, pharmaceutical company and includes a wealth of information on the financial trends over the past four years. latest Pharmaceuticals analysis is perfect for investors to: See the ...  |  read more...
USD 525
Antobiotic Manufacturers, Global
10/2/2014 | published by: Plimsoll Publishing Ltd.
... report includes a wealth of information on the financial trends over the past four years. latest Antobiotic Manufacturers Global analysis is perfect for investors to: See the market leaders Identify companies heading for failure Seek ...  |  read more...
USD 1,425
Pharmaceuticals and Healthcare Report - Belarus Q4 2014
10/1/2014 | published by: Business Monitor International
... Ukraine andRussia and absolute erosion of consumer purchasing power. Geopolitical tension between Russia andUkraine will continue to impact trading volumes in the region, with a full-blown conflict posing a seriousthreat to the Belarusian economy. Belarus ...  |  read more...
USD 1,295
Norway Pharmaceuticals and Healthcare Report Q4 2014
10/1/2014 | published by: Business Monitor International
... the patented drugssector will not translate into an equivalent gain for the generic drugs market as a result of the much lowercost of generics. Headline Expenditure Projections Pharmaceuticals: NOK19.90bn (USD3.36bn) in 2013 to NOK20.28bn (USD3.29bn) ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Ukraine Q4 2014
10/1/2014 | published by: Business Monitor International
... severe devaluation of the hryvnia inthe country, drugmakers can expect a challenging business environment as capital outflow restrictions havebeen recently implemented. Import taxes, pricing restrictions, and exchange rate volatility presentsignificant risks to drugmakers operating in ...  |  read more...
USD 1,295
Bangladesh Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... fiscal year 2014/2015 as a sound investment. While we are optimistic thatongoing tax reform efforts by the government will rake in more revenues to support development spending,and keep the country's budget deficit manageable at around ...  |  read more...
USD 1,295
Central America Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... spending and strong consumer demand still present strong revenue-generatingopportunities for multimodal pharmaceutical companies. Headline Expenditure Projections Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10